What is the impact of HIV infection on survival after liver transplantation? Commentary

Nature Clinical Practice Gastroenterology and Hepatology

Volumn 5, Issue 8, 2008, Pages 426-427

  Kemmer, Nyingi ^a   Sherman, Kenneth E ^a  

^a UNIVERSITY OF CINCINNATI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; INTERFERON; RAPAMYCIN; TACROLIMUS;

DEATH; DRUG COMPETITION; DRUG EFFICACY; DRUG MONITORING; FOLLOW UP; GRAFT RECIPIENT; HAZARD RATIO; HEPATITIS B; HEPATITIS C; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOSUPPRESSIVE TREATMENT; LIVER FAILURE; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; MIXED INFECTION; MORBIDITY; MORTALITY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RECURRENCE RISK; REGRESSION ANALYSIS; RETROSPECTIVE STUDY; SHORT SURVEY; STATISTICAL SIGNIFICANCE; SURGICAL TECHNIQUE; SURVIVAL RATE; TREATMENT CONTRAINDICATION; TREATMENT OUTCOME; UNITED STATES;

EID: 49249121490     PISSN: 17434378     EISSN: 17434386     Source Type: Journal    
DOI: 10.1038/ncpgasthep1182     Document Type: Short Survey

References (5)

1. Pineda JA and Garcia-Garcia JA et al. (2007) Clinical progression of hepatitis C virus-related chronic liver disease in human immunodeficiency virus-infected patients undergoing highly active antiretroviral therapy. Hepatology 46: 622-630
2. Samuel D et al. (2008) Are HIV-infected patients candidates for liver transplantation? J Hepatol 48: 697-707
3. Stock PG and Roland ME (2007) Evolving clinical strategies for transplantation in the HIV-positive recipient. Transplantation 84: 563-571
4. Duclos-Vallee JC et al. (2008) Survival and recurrence of hepatitis C after liver transplantation in patients coinfected with human immunodeficiency virus and hepatitis C virus. Hepatology 47: 407-417
5. Roland ME et al. (2008) HIV-infected liver and kidney transplant recipients: 1- and 3-year outcomes. Am J Transplant 8: 355-365